Lexicon Pharmaceuticals Ownership | Who Owns Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals Ownership Summary
Lexicon Pharmaceuticals is owned by 3.94% institutional investors, 1.17% insiders, and 94.88% retail investors. Artal group is the largest institutional shareholder, holding 37.48% of LXRX shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 5.64% of its assets in Lexicon Pharmaceuticals shares.
LXRX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Lexicon Pharmaceuticals | 3.94% | 1.17% | 94.88% |
| Sector | Healthcare Stocks | 42.53% | 10.81% | 46.67% |
| Industry | Biotech Stocks | 45.24% | 10.75% | 44.01% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Artal group | 136.18M | 37.48% | $183.84M |
| Siren | 38.92M | 10.71% | $52.54M |
| Fmr | 38.68M | 10.65% | $52.22M |
| Blackrock | 9.89M | 4.03% | $16.62M |
| Vanguard group | 9.52M | 2.62% | $12.85M |
| Blackrock funding, inc. /de | 3.39M | 0.93% | $4.58M |
| Sessa capital im | 3.00M | 0.83% | $4.05M |
| Cibc private wealth group | 2.45M | 0.67% | $2.32M |
| Geode capital management | 2.40M | 0.66% | $3.24M |
| Gsa capital partners llp | 1.20M | 0.33% | $1.62M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Artal group | 136.18M | 24.25% | $183.84M |
| Siren | 38.92M | 2.06% | $52.54M |
| Gsa capital partners llp | 1.20M | 0.14% | $1.62M |
| Sessa capital im | 3.00M | 0.10% | $4.05M |
| Hennion & walsh asset management | 779.21K | 0.04% | $1.05M |
| Cvi | 20.00K | 0.03% | $33.60K |
| Monaco asset management sam | 350.00K | 0.03% | $472.50K |
| Ikarian capital | 176.48K | 0.02% | $238.25K |
| Xtx topco | 329.54K | 0.02% | $444.87K |
| Straight path wealth management | 62.67K | 0.02% | $84.60K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 9.89M | 0.00% | 2.20M |
| Vanguard group | 9.52M | 0.00% | 670.84K |
| Fmr | 38.68M | 0.00% | 542.21K |
| Susquehanna group, llp | 550.89K | 0.00% | 463.39K |
| Renaissance | 292.40K | 0.00% | 292.40K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Orbimed advisors | - | - | -11.02M |
| Point72 asset management | - | - | -8.99M |
| Schonfeld strategic advisors | 825.63K | 0.01% | -3.75M |
| Nea management company | - | - | -2.38M |
| Ameriprise financial | - | - | -2.33M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Renaissance | 292.40K | 0.00% | 292.40K | $394.74K |
| Quadrature capital | 228.21K | 0.00% | 228.21K | $309.22K |
| Jefferies financial group | 97.40K | 0.00% | 97.40K | $131.49M |
| Headlands | 49.65K | 0.01% | 49.65K | $67.02K |
| Prudential financial | 35.00K | 0.00% | 35.00K | $47.24K |
Sold Out
| Holder | Change |
|---|---|
| Newedge advisors | -5.00 |
| Federated hermes | -6.00 |
| Capital performance advisors llp | -18.00 |
| Nelson, van denburg & campbell wealth management group | -21.00 |
| Tortoise investment management | -21.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 48 | -60.66% | 14,323,194 | -94.37% | 3 | 0.08% | 11 | -81.03% | 15 | -57.14% |
| Jun 30, 2025 | 126 | -3.82% | 256,258,970 | -3.59% | 70 | 1.31% | 59 | -11.94% | 38 | 18.75% |
| Mar 31, 2025 | 130 | -1.52% | 265,798,118 | -10.70% | 73 | 1.08% | 66 | -5.71% | 33 | 32.00% |
| Dec 31, 2024 | 122 | -12.23% | 294,769,499 | 2.13% | 81 | 1.28% | 68 | -2.86% | 20 | -4.76% |
| Sep 30, 2024 | 138 | 6.15% | 288,617,050 | 3.46% | 79 | 0.62% | 70 | -2.78% | 21 | -8.70% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl O | 20.40M | 5.64% | 2.23M |
| Fidelity Growth Compy Commingled Pl S | 18.09M | 4.98% | 544.22K |
| Fidelity Growth Company Fund | 12.39M | 3.41% | 329.91K |
| Vanguard Total Stock Mkt Idx Inv | 5.04M | 1.39% | -111.18K |
| Fidelity Growth Company K6 | 3.96M | 1.09% | 168.97K |
| Vanguard US Total Market Shares ETF | 3.89M | 1.08% | - |
| Fidelity Series Growth Company | 3.23M | 0.89% | 108.80K |
| iShares Russell 2000 ETF | 2.88M | 0.79% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.99M | 0.55% | -908.61K |
| Columbia Small Cap Value I A | 1.91M | 0.53% | 497.77K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
| 2024 Q4 | - | - |
| 2024 Q3 | - | - |
| 2024 Q2 | - | - |
LXRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools